Home > Boards > US OTC > Medical - Equipment >

Lifeline Biotechnologies, Inc. (LLBO)

Add LLBO Price Alert      Hide Sticky   Hide Intro
Moderator: Arnie1, Homebrew, leprisonnier, rmilman, PharrmaBro
Search This Board: 
Last Post: 1/17/2020 4:56:28 PM - Followers: 280 - Board type: Free - Posts Today: 0

Cyrcadia Asia, Hong Konghttps://www.rouse.com/magazine/news/rouse-ventures-team-scores-win-for-breast-cancer-detection-wearable-cyrcadia/



Lifeline Biotechnologies Provides Information To The Public And Its Shareholders

Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter

by admin | Feb 21, 2018 | NewsFebruary 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with CA, whereby CA assumed the responsibility and funding of the design, development and delivery of a scalable, commercializable iTBra™ system including upgraded hardware and the full suite of application software as well as automation of our proprietary Artificial Intelligence Analytics. The estimated cost of development with Jabil and Mobile Now is approximately $1.2 to $1.5 million US. As such, the agreement calls for CA to provide timely reporting and status of product development including timelines, milestones and dates of completion and delivery of product (market readiness, product volume availability and delivery terms and schedules). Many strides have been made in the evolution of the relationship as CA has established its operations, initial staffing and funding. Both CI and CA are in a mode of cooperation, as called for by the Agreement and, presently, both entities are to hold routine meetings where comprehensive updating and reporting will be delivered to CI, enabling implementation of our business, operations and marketing plans. We will be reporting the outcomes of that meeting to move forward on our ability to commercialize the iTBra™ system this year. Given the above, we would like to update on the internal operations that will allow for CI to “hit the ground running” upon product delivery. Status of Product Development and Manufacturing Under CA’s...

Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!

Clinical Trial

In Progress - To Be Completed

** Funding for Clinical Trial

** Vendor delivery of testing materials

Completed for Clinical Trial

** Protocol for testing accepted

** Internal Review Board (IRB) approved

** Contract with hospital executed

Prospective Partner

** Stanford University's Canary Research

Research in blood genomics


The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe. 


Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.

About $LLBO - Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:

This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

http://www.firstwarningsystems.com/ became Cyrcadia Health http://cyrcadiahealth.com/

$LLBO is Cyrcadia's largest shareholder at approximately 40%

Transfer Agent

OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753

Share Structure
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001

Company Information

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. http://www.lbti.com

About Cyrcadia Health

Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at http://www.cyrcadiahealth.com/

iTBra in the News

ABC 7 News - February 5, 2015


ABC 7 News - February 5, 2015

ABC 7 News - January 30, 2015

Good Monring America apperance coming....
Quote from the March 12, 2015 PR

They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.


Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine




Documentary Movie: Detected coming....
Funded by Cisco
Detected Trailer...

Detected trailer on Cisco's facebook page
Detected: Behind the Scenes with Ironbound Films
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

Can the IoE Save Lives? Connected Bra Could Predict Cancer
By: Cisco's Senior Vice President and Chief Marketing Officer

Detected Website http://detectedmovie.com/
Detected Facebook https://www.facebook.com/detectedmovie
Detected Twitter https://twitter.com/detectedmovie

Partnered with Flextronics

Cyrcadia Health Partners

In Israel at Flextronics



iTBra Already Saved Nedra Lindsay's Life - See Her Story

Final Clinical Trials, FDA plans and other info from - March 12, 2015 Press Release

...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.


It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.


Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.


They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.




Detected Movie Youtube channel

Video News Clipping ABC7 Los Angeles Health News - Breast Cancer Detecting Bra

Detected: Behind the Scenes with Ironbound Films

Wearable & Social Breast Cancer Screening

Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

GameChanger of the Year: Cyrcadia

$LLBO infograph, DD in a nutshell

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#29659  Sticky Note JIM Holmes /LLBO is a SCAM !!! PharrmaBro 09/25/19 12:36:33 PM
#25922  Sticky Note “New”Investor Information: confirm 07/17/18 08:30:45 AM
#30044   1 week left!!! Before it becomes a 9yrswaiting 01/17/20 04:56:28 PM
#30043   CRICKETS! Where r all the long and techhead 01/17/20 03:06:31 PM
#30041   What happens if he does’t? Are you 9yrswaiting 01/15/20 05:57:36 PM
#30040   I would bet 5mil shares we hear nothing techhead 01/15/20 02:25:47 PM
#30039   IMO Jim Holmes will come out with a Arnie1 01/15/20 10:54:05 AM
#30038   Crickets. mark5050 01/15/20 10:46:42 AM
#30037   Cyrcadia usually gives a update end of Jan- PharrmaBro 01/15/20 09:23:48 AM
#30036   Jim Holmes is not responding to some shareholder techhead 01/15/20 05:29:14 AM
#30035   Try- key word. He can respond to techhead 01/14/20 08:46:03 AM
#30034   PB: I have full confidence that JH will Arnie1 01/13/20 05:20:12 PM
#30033   Expect more delays more promises PharrmaBro 01/13/20 04:40:36 PM
#30029   Good morning Folks! This morning I received Arnie1 01/13/20 09:27:16 AM
#30027   There is nothing moves faster then biotech plays Chaka 01/10/20 08:27:49 PM
#30025   Cool. TIME IS $$$. Chaka 01/10/20 08:25:51 PM
#30024  Restored If losing over 100% is a metric for starkd748 01/10/20 08:24:26 PM
#30022   Dude.. So is AMAZON years ago down 94%. Chaka 01/10/20 08:12:29 PM
#30021  Restored Dude this piece of shit is down over starkd748 01/10/20 08:07:10 PM
#30020   My friend.. Chaka 01/10/20 08:05:11 PM
#30019   HAPPY NEW YEAR'S TO ALL THE LONGS ON HERE.. Chaka 01/10/20 08:03:07 PM
#30018   WRONG. Chaka 01/10/20 08:02:22 PM
#30017   Copy and paste it 9yrswaiting 01/10/20 01:13:11 AM
#30016   First I do not know how to transfer Arnie1 01/09/20 10:00:47 AM
#30015   You should post the email so every one techhead 01/09/20 09:44:25 AM
#30014   Yesterday I received an email from JH in Arnie1 01/09/20 09:42:52 AM
#30013   Has there been any news or PR in MaverickTT 01/07/20 09:16:20 PM
#30012   Tony you're 100 percent right!! And I agree!! Arnie1 01/06/20 07:09:11 AM
#30011   Why do some continue to bring up technologies tonyb2232 01/06/20 01:47:03 AM
#30010   Welcome back Arnie1... yes... me too... I’m hoping Luckyyu 01/05/20 09:28:41 PM
#30009   Lucky you I am back from the Philippines Arnie1 01/05/20 09:27:29 PM
#30008   The smart one was the one selling techhead 01/03/20 03:51:49 PM
#30007   Someone is buying 0.0011's - is there any news? rrao11 01/02/20 01:54:46 PM
#30006   Google’s new AI detects breast cancer just by PharrmaBro 01/02/20 09:34:22 AM
#30003   I stumbled on this piece of rereading some starkd748 12/31/19 04:51:15 PM
#30002   No money no clients no FDA approval shouldn't starkd748 12/31/19 04:49:50 PM
#30001   Wow this piece of shit finally hit trippppppy starkd748 12/31/19 04:48:26 PM
#30000   Best wishes to ALL leprisonnier 12/31/19 04:45:43 PM
#29998   It goes down 0.009, very disappointing, i think yaro1 12/31/19 03:13:56 PM
#29997   Not long before investors in Asia realize they PharrmaBro 12/31/19 01:39:01 PM
#29996   Oooh how exciting!! PharrmaBro 12/31/19 01:31:40 PM
#29995   THE END IS NEAR 76cruiser 12/30/19 10:32:39 PM
#29994   i did. it's been 11yrs and i figured ctic0_05 12/30/19 02:03:33 PM
#29993   0.0005,right? mark5050 12/30/19 01:31:59 PM
#29992   Tomorrow it will be “who bought at .005. techhead 12/30/19 01:18:29 PM
#29991   Who sold in a single trade techhead 12/30/19 12:05:16 PM
#29990   Who bought 5M today in a single trade? yaro1 12/30/19 10:07:04 AM
#29989   Arnie, I just now went to check it Luckyyu 12/29/19 05:30:22 PM
#29988   Hi Luckyyu! Have you noticed that CHI Arnie1 12/29/19 05:25:36 PM
#29987   Loved... Luckyyu: Thank you!! Hopefully, things will be better Luckyyu 12/27/19 01:28:19 AM
#29986   Luckyyu: Thank you!! Hopefully, things will be better Arnie1 12/26/19 11:46:24 PM
#29985   Happy Holidays Arnie!!!! Enjoy your trip! That Luckyyu 12/26/19 11:02:00 PM